Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05178381 · ClinicalTrials.gov registry record · NA

Evaluating the Neurocomputational Mechanisms of Explore-Exploit Decision Making in Older Adults

A NA study of Healthy Aging, sponsored by University of Arizona.

Completed
Registry status
NA
Development phase
248
Enrollment target
1
Study location

NCT05178381: Completed NA study of Healthy Aging, sponsored by University of Arizona.

NCT05178381 is a NA study of Healthy Aging that has completed, run by University of Arizona. The registered enrollment target is 248 participants, above the 115-participant average among 40 other Healthy Aging trials with a reported enrollment target (116% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05178381, a NA study of Healthy Aging, has completed, sponsored by University of Arizona.

COMPLETED
Registry status
NA
Development phase
248 participants
Enrollment target
1
Study location

Study Summary

The full experiment involves participants coming into the lab on five separate occasions for neuropsychological testing, a decision making battery, functional and structural MRI, and two TMS sessions for stimulation of the target or control stimulation site. The clinical trial component concerns only the last two sessions where subjects will be randomly assigned to different groups to receive different TMS interventions. In particular, the TMS experiments will ask two main questions: 1. What is the causal role of frontal pole in explore-exploit behavior in younger and older adults? 2. What is the causal role of IFG in explore-exploit behavior in younger and older adults? The investigators will use continuous theta-burst transcranial magnetic stimulation (cTBS, Huang et al. 2005) to inhibit neural activity in each region for approximately 50 minutes (Wischnewski \& Schutter, 2015) and measure the downstream effects on behavior in younger and older adults. Consistent with their respective roles in the explore-exploit circuit (Figure 5 in Research Strategy), the investigators predict that inhibition of frontal pole will lead to a selective reduction in directed, but not random, exploration, while inhibition of IFG will decrease exploitation and lead to increases in both types of exploration. Participants in each age group will be pseudo-randomly assigned to either the frontal pole group or IFG group such that the study will have 42 participants (21 males, 21 females) in each group. Thus there will be four distinct groups of subjects older frontal pole, younger frontal pole, older IFG, younger IFG. Each participant will take part in two TMS sessions, one target and one control session. The order of sessions will be counterbalanced across subjects. The primary endpoints of the study are to determine whether: 1. cTBS applied to frontal pole inhibits directed exploration within the younger and older groups 2. cTBS applied to IFG promotes both directed and random expl

Primary Outcome

Change in directed exploration as a result of stimulation to target vs control site. Directed exploration will be measured using the Horizon Task (Wilson et al. 2014) in which directed exploration is defined as the change in p(high info) between horizon 1 and horizon 6.

Conditions Studied

Interventions

  • DEVICE Continuous theta burst transcranial magnetic stimulation

Study Locations (1)

Arizona

  • University of Arizona - Tucson

Trial Details

FieldValue
Enrollment Target 248 participants
Start Date 2022-10-01
Est. Completion 2024-08-01
Phase NA
University of Arizona

349 total trials

What the finished NCT05178381 record still lists

NCT05178381 is an interventional study that assigns participants to a tested intervention. The registered 248 participants enrollment target is mid-sized for trials with a published cap, above the 115-participant average among 40 other Healthy Aging trials with a reported enrollment target (116% higher).

The record links to 1 condition, with Healthy Aging appearing as the primary indexed condition, and to 1 intervention - of which Continuous theta burst transcranial magnetic stimulation is the first listed.

NCT05178381 reports a single indexed study location in Arizona.

Frequently Asked Questions

What is clinical trial NCT05178381 about?

NCT05178381 is a clinical study titled "Evaluating the Neurocomputational Mechanisms of Explore-Exploit Decision Making in Older Adults". The full experiment involves participants coming into the lab on five separate occasions for neuropsychological testing, a decision making battery, functional and structural MRI, and two TMS sessions for stimulation of the target or control stimulation site. The clinical trial component concerns onl...

What is the current status of trial NCT05178381?

This trial is currently completed. It is a NA study. The enrollment target is 248 participants. The study started on 2022-10-01. Estimated completion is 2024-08-01.

What conditions does trial NCT05178381 study?

This clinical trial studies the following conditions: Healthy Aging.

What interventions are being tested in trial NCT05178381?

The interventions under investigation include: Continuous theta burst transcranial magnetic stimulation (DEVICE).

Who is sponsoring clinical trial NCT05178381?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05178381 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05178381's enrollment target sits among peer trials

248 7th of 40 higher than 34 of 40 other Healthy Aging trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04577911 · 248 participants

    How is Social Connection Represented in the Brain?

  • NCT04777994 · 248 participants · Phase 1

    Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

  • NCT04792489 · 248 participants · Phase 2

    DALY II USA/ MB-CART2019.1 for DLBCL

  • NCT04830137 · 248 participants · Phase 1

    A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05178381, the US trial registry maintained by the National Library of Medicine. NCT05178381 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.